Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Enterprise Value: 2019-2025

Historic Enterprise Value for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $38.8 million.

  • Biodesix's Enterprise Value fell 82.93% to $38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.8 million, marking a year-over-year decrease of 117.57%. This contributed to the annual value of $196.3 million for FY2024, which is 40.04% up from last year.
  • Latest data reveals that Biodesix reported Enterprise Value of $38.8 million as of Q3 2025, which was up 87.81% from $20.6 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Enterprise Value registered a high of $340.9 million during Q1 2021, and its lowest value of $20.6 million during Q2 2025.
  • In the last 3 years, Biodesix's Enterprise Value had a median value of $119.8 million in 2023 and averaged $115.1 million.
  • Over the last 5 years, Biodesix's Enterprise Value had its largest YoY gain of 2,837.64% in 2021, and its largest YoY loss of 92.64% in 2021.
  • Quarterly analysis of 5 years shows Biodesix's Enterprise Value stood at $34.8 million in 2021, then skyrocketed by 54.33% to $53.7 million in 2022, then surged by 160.93% to $140.2 million in 2023, then surged by 40.04% to $196.3 million in 2024, then tumbled by 82.93% to $38.8 million in 2025.
  • Its last three reported values are $38.8 million in Q3 2025, $20.6 million for Q2 2025, and $73.7 million during Q1 2025.